BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24068579)

  • 21. Docking analysis and resistance evaluation of clinically relevant mutations associated with the HIV-1 non-nucleoside reverse transcriptase inhibitors nevirapine, efavirenz and etravirine.
    Alcaro S; Alteri C; Artese A; Ceccherini-Silberstein F; Costa G; Ortuso F; Bertoli A; Forbici F; Santoro MM; Parrotta L; Flandre P; Masquelier B; Descamps D; Calvez V; Marcelin AG; Perno CF; Sing T; Svicher V
    ChemMedChem; 2011 Dec; 6(12):2203-13. PubMed ID: 21953939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlays.
    Jones LH; Allan G; Barba O; Burt C; Corbau R; Dupont T; Knöchel T; Irving S; Middleton DS; Mowbray CE; Perros M; Ringrose H; Swain NA; Webster R; Westby M; Phillips C
    J Med Chem; 2009 Feb; 52(4):1219-23. PubMed ID: 19175319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors.
    Ren J; Nichols C; Bird L; Chamberlain P; Weaver K; Short S; Stuart DI; Stammers DK
    J Mol Biol; 2001 Sep; 312(4):795-805. PubMed ID: 11575933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
    Auwerx J; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of novel inhibitors of HIV-1 reverse transcriptase with a reporter ribozyme assay.
    Yamazaki S; Famulok M
    Methods Mol Biol; 2009; 535():187-99. PubMed ID: 19377995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
    Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
    J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz.
    Kollmann C; Tremblay C; Giguel F; Chou TC; Hirsch MS
    Antivir Ther; 2001 Jun; 6(2):143-4. PubMed ID: 11491419
    [No Abstract]   [Full Text] [Related]  

  • 28. Structure-enhanced methods in the development of non-nucleoside inhibitors targeting HIV reverse transcriptase variants.
    Frey KM
    Future Microbiol; 2015; 10(11):1767-72. PubMed ID: 26517310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity.
    Campiani G; Nacci V; Fiorini I; De Filippis MP; Garofalo A; Greco G; Novellino E; Altamura S; Di Renzo L
    J Med Chem; 1996 Jul; 39(14):2672-80. PubMed ID: 8709096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of inhibition of HIV-1 reverse transcriptase by the novel broad-range DNA polymerase inhibitor N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-(2-thienyl)acetamide.
    Herschhorn A; Oz-Gleenberg I; Hizi A
    Biochemistry; 2008 Jan; 47(1):490-502. PubMed ID: 18052256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase.
    Zhou Z; Madrid M; Evanseck JD; Madura JD
    J Am Chem Soc; 2005 Dec; 127(49):17253-60. PubMed ID: 16332074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors.
    Lu X; Chen Y; Guo Y; Liu Z; Shi Y; Xu Y; Wang X; Zhang Z; Liu J
    Bioorg Med Chem; 2007 Dec; 15(23):7399-407. PubMed ID: 17870545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of selected South African medicinal plants for inhibitory properties against human immunodeficiency virus type 1 reverse transcriptase and integrase.
    Bessong PO; Obi CL; Andréola ML; Rojas LB; Pouységu L; Igumbor E; Meyer JJ; Quideau S; Litvak S
    J Ethnopharmacol; 2005 May; 99(1):83-91. PubMed ID: 15848024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Efavirenz Derivatives and 1,2,3-Triazolyl-phosphonates as Inhibitors of Reverse Transcriptase of HIV-1.
    Costa CCP; Boechat N; Bastos MM; da Silva FC; Marttorelli A; Souza TML; Baptista MS; Hoelz LVB; Cafffarena ER
    Curr Top Med Chem; 2018; 18(17):1494-1505. PubMed ID: 30370848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient kinetic analyses of the ribonuclease H cleavage activity of HIV-1 reverse transcriptase in complex with efavirenz and/or a β-thujaplicinol analogue.
    Herman BD; Sluis-Cremer N
    Biochem J; 2013 Oct; 455(2):179-84. PubMed ID: 23927736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virtual screening, identification, and biochemical characterization of novel inhibitors of the reverse transcriptase of human immunodeficiency virus type-1.
    Herschhorn A; Hizi A
    J Med Chem; 2008 Sep; 51(18):5702-13. PubMed ID: 18800765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency.
    Nikolenko GN; Svarovskaia ES; Delviks KA; Pathak VK
    J Virol; 2004 Aug; 78(16):8761-70. PubMed ID: 15280484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Truncated reverse isoxazolidinyl nucleosides: a new class of allosteric HIV-1 reverse transcriptase inhibitors.
    Romeo R; Giofrè SV; Macchi B; Balestrieri E; Mastino A; Merino P; Carnovale C; Romeo G; Chiacchio U
    ChemMedChem; 2012 Apr; 7(4):565-9. PubMed ID: 22323191
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of a pseudovirus assay and evaluation to screen natural products for inhibition of HIV-1 subtype C reverse transcriptase.
    Mavhandu LG; Cheng H; Bor YC; Tebit DM; Hammarskjold ML; Rekosh D; Bessong PO
    J Ethnopharmacol; 2020 Aug; 258():112931. PubMed ID: 32360797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.